The characteristics of the stricture, but not the ongoing treatment, could influence the outcome of endoscopic dilation in recurrent Crohn's disease.

[1]  M. Silverberg,et al.  Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group. , 2020, The lancet. Gastroenterology & hepatology.

[2]  L. Stassen,et al.  ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment. , 2019, Journal of Crohn's & colitis.

[3]  X. Calvet,et al.  Efficacy and safety of endoscopic balloon dilation in inflammatory bowel disease: results of the large multicenter study of the ENEIDA registry , 2019, Surgical Endoscopy.

[4]  T. Kim,et al.  Long-Term Outcomes of Endoscopic Balloon Dilation for Benign Strictures in Patients with Inflammatory Bowel Disease , 2018, Gut and liver.

[5]  G. Van Assche,et al.  Endoscopic management of Crohn’s strictures , 2018, World journal of gastroenterology.

[6]  R. Leong,et al.  Crohn's disease associated strictures , 2018, Journal of gastroenterology and hepatology.

[7]  N. Kato,et al.  Long-Term Outcome of Endoscopic Balloon Dilatation for Strictures in Patients with Crohn’s Disease , 2018, Digestion.

[8]  M. Johnston,et al.  Endoscopic balloon dilatation of Crohn's strictures: a safe method to defer surgery in selective cases , 2017, ANZ journal of surgery.

[9]  T. Baron,et al.  Endoscopic balloon dilation of Crohn’s disease strictures-safety, efficacy and clinical impact , 2017, World journal of gastroenterology.

[10]  G. Van Assche,et al.  A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn's Disease , 2017, Inflammatory bowel diseases.

[11]  U. Navaneethan,et al.  Endoscopic balloon dilation in the management of strictures in Crohn’s disease: a systematic review and meta-analysis of non-randomized trials , 2016, Surgical Endoscopy.

[12]  A. Hart,et al.  Endoscopic Dilatation of Crohn's Anastomotic Strictures is Effective in the Long Term, and Escalation of Medical Therapy Improves Outcomes in the Biologic Era. , 2016, Journal of Crohn's & colitis.

[13]  O. Faiz,et al.  Systematic review with meta‐analysis: endoscopic balloon dilatation for Crohn's disease strictures , 2015, Alimentary pharmacology & therapeutics.

[14]  J. Halfvarson,et al.  Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn's disease , 2012, Alimentary pharmacology & therapeutics.

[15]  B. Petersen,et al.  A lexicon for endoscopic adverse events: report of an ASGE workshop. , 2010, Gastrointestinal endoscopy.

[16]  P. Rutgeerts,et al.  Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy , 2009, Gut.

[17]  L. Biancone,et al.  Frequency, Pattern, and Risk Factors of Postoperative Recurrence of Crohn’s Disease After Resection Different from Ileo-Colonic , 2009, Journal of Gastrointestinal Surgery.

[18]  W. Reinisch,et al.  Safety and efficacy of endoscopic balloon dilation for treatment of Crohn's disease strictures. , 2006, Endoscopy.

[19]  Syed G. Shah,et al.  Colonoscopic balloon dilation of Crohn's strictures: a review of long‐term outcomes , 2003, European journal of gastroenterology & hepatology.

[20]  P. Rutgeerts.  Strategies in the prevention of post-operative recurrence in Crohn's disease. , 2003, Best practice & research. Clinical gastroenterology.

[21]  P. Tighe,et al.  Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. , 2002, American journal of physiology. Cell physiology.

[22]  J. Reimund,et al.  Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. , 1996, Gut.

[23]  P. Rutgeerts,et al.  Predictability of the postoperative course of Crohn's disease. , 1990, Gastroenterology.